SCHEMBL648003

SCHEMBL648003

CC(C)OC=C(Br)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL650579 1.00
SCHEMBL1544551 1.00
SCHEMBL16327975 0.76
SCHEMBL13848749 0.72
SCHEMBL11163142 0.70
SCHEMBL8626148 0.70
SCHEMBL12704754 0.70
SCHEMBL11495563 0.70
SCHEMBL14297400 0.70
SCHEMBL13792239 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899328-B1 A PROCESS FOR THE PREPARATION OF LOSARTAN DERIVATIVES BY CHLORINATION AND REDUCTION OF THE RESPECTIVE 1H-IMIDAZOLE-5-CARBALDEHYDES KRKA D D NOVO MESTO (SI) 2009-03-04 EP claimed
EP-1899328-A1 A PROCESS FOR THE PREPARATION OF LOSARTAN DERIVATIVES BY CHLORINATION AND REDUCTION OF THE RESPECTIVE 1H-IMIDAZOLE-5-CARBALDEHYDES KRKA, D.D., Novo Mesto (SI) 2008-03-19 EP claimed
WO-2007003280-A1 A PROCESS FOR THE PREPARATION OF LOSARTAN DERIVATIVES BY CHLORINATION AND REDUCTION OF THE RESPECTIVE 1H-IMIDAZOLE-5-CARBALDEHYDES KRKA, D.D. NOVO MESTO (SI) 2007-01-11 WO claimed
EP-1741711-A1 A process for the preparation of losartan derivatives by chlorination and reduction of the respective 1H-imidazole-5-carbaldehydes KRKA, D.D., Novo Mesto (SI) 2007-01-10 EP claimed
EP-4192831-A1 HETEROCYCLIC GLP-1 AGONISTS Gasherbrum Bio, Inc. (US) 2023-06-14 EP disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
CN-111978257-A Synthesis method of aldehyde group and carboxyl group-containing 1-methyl arene-1H-imidazole series compounds 武汉药明康德新药开发有限公司 2020-11-24 CN disclosed
WO-2017069601-A1 SUBSTITUTED AMINOALKYLAZOLES AS MALARIAL ASPARTIC PROTEASE INHIBITORS LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) 2017-04-27 WO disclosed
US-8703776-B2 Agonists of GPR131 and uses thereof CYMABAY THERAPEUTICS, INC. (US) 2014-04-22 US disclosed
US-20130059856-A1 AGONISTS OF GPR131 AND USES THEREOF METABOLEX, INC. 2013-03-07 US disclosed
WO-2012174164-A2 AGONISTS OF GPR131 AND USES THEREOF METABOLEX, INC. (US) 2012-12-20 WO disclosed
US-8309542-B2 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-11-13 US disclosed
EP-0850225-A1 INTERMEDIATE FOR PREPARING A PHARMACEUTICALLY ACTIVE COMPOUND SMITHKLINE BEECHAM CORPORATION (US) 1998-07-01 EP disclosed
US-5719293-A Intermediate for preparing a pharmaceutically active compound SMITHKLINE BEECHAM CORPORATION (US) 1998-02-17 US disclosed
CN-1151734-A Intermediate for prepairing a pharmaceutically active compound SMITHKLINE BEECHAM CORP (US) 1997-06-11 CN disclosed
US-5565577-A Process for preparing 1-alkyaryl-2-alkyl-5-formylimidazole SMITHKLINE BEECHAM CORPORATION (US) 1996-10-15 US disclosed
EP-0662961-A4 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS. SMITHKLINE BEECHAM CORP (US) 1996-07-31 EP disclosed
WO-1995032189-A1 INTERMEDIATE FOR PREPARING A PHARMACEUTICALLY ACTIVE COMPOUND SMITHKLINE BEECHAM CORPORATION (US) 1995-11-30 WO disclosed
EP-0662961-A1 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-07-19 EP disclosed
WO-1994006776-A1 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1994-03-31 WO disclosed